Supreme Court Lawyer Devesh Tripathi receives Honorary Doctorate from University of California.

New Delhi [India], October 13: Corporate Lawyer Devesh Tripathi received Honorary Doctorate in Business Management from California University San Diego USA, for his extensive contribution in Corporate and International Taxation

The university awards honorary doctorates recognizing individuals who have made lasting contributions to their respective fields, advancing knowledge, research and policy that benefit society at large.  Dr Tripathi is recognized for his outstanding contributions to the study of Commercial law, the rule of law and legal theory.

Dr Tripathi received the Honorary Doctorate in a unique online ceremony which was filmed for a special movie documenting this year’s innovative ‘Alternative Graduation’. He said: “It is a true privilege to receive this honour. We must all work together; honesty and integrity are the most important qualities.”

One can play a variety of roles and one can still dedicate one’s legal career to the pursuit of social justice and social change, particularly in countries which need it.

Thinking about new lawyers graduating this year,  Dr Tripathi encouraged them to devote some time to pro bono work as they develop their careers. He said: “I think it’s a wonderful thing to have a multi-disciplinary practice, so even if you want to focus on competition law, business law or on banking, ensuring that a part of your practice involves pro bono work to assist social change makes for a rounded practice and a rounded lawyer

Dr Tripathi has extensive experience across international arbitration, sanctions law, dispute resolution, and corporate law. Dr. Devesh Tripathi completed his B.Sc. from Dr. RML Avadh University, Ayodhya, in 1998, followed by an M.A. in Ancient History and Culture from CSJM Kanpur University in 2000. In 2011, he earned his LL.B. from Meerut University and later completed a PGD (IPR) from Mumbai University. He is currently enrolled as an Advocate with the Bar Council of Delhi.

With experience across Taxation, Corporate, Criminal, and Intellectual Property Law, he founded Eminent Jurists Law Firm in 2011. His expertise lies in Taxation and Corporate Law litigation, where he has handled complex cases under various Acts. He has also been a guest speaker at forums such as BIF, co-authored articles, and remains a lifetime member of the Supreme Court Bar Association, New Delhi.

As the Founding President of the National Economic Forum (NEF), he champions economic transformation and national progress, partnering with trade organisations and governments to drive positive change.

His current subject of research for the Garwood Fellowship at University of California Berkeley  is “How to Expand Markets into India.”

Dr Tripathi and his fellow honorees are exceptional individuals whose achievements have had a profound impact in their fields and beyond, said Professor Karen O’Brien, Vice-Chancellor of the University.

They reflect the values we hold dear as a University: excellence, creativity, integrity and making a positive difference in the world,” says Vice-Chancellor O’Brien. “As our students graduate and begin the next chapter of their journeys, they can look to these distinguished figures as role models and draw encouragement from the diverse paths they have forged.”

Please visit https://drdeveshtripathi.com

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More